Toggle light / dark theme

OpenAI will still let researchers use the model.


Microsoft has expanded its ongoing partnership with San Francisco-based artificial intelligence research company OpenAI with a new exclusive license on the AI firm’s groundbreaking GPT-3 language model, an auto-generating text program that’s emerged as the most sophisticated of its kind in the industry.

The two companies are already entwined through OpenAI’s ongoing Azure cloud computing contract, with Azure being the platform on which OpenAI accesses the vast computing resources it needs to train many of its models, and a major $1 billion investment Microsoft made last year to become OpenAI’s exclusive cloud provider. Now, Microsoft is issuing yet another signal of high confidence in OpenAI’s research by acquiring the rights to GPT-3.

OpenAI released GPT-3, the third iteration of its ever-growing language model, in July, and the program and its prior iterations have helped create some of the most fascinating AI language experiments to date. It’s also inspired vigorous debate around the ethics of powerful AI programs that may be used for more nefarious purposes, with OpenAI initially refusing to publish research about the model for fear it would be misused.

While critically ill patients experience a life-threatening illness, they commonly contract ventilator-associated pneumonia. This nosocomial infection increases morbidity and likely mortality as well as the cost of health care. This article reviews the literature with regard to diagnosis, treatment, and prevention. It provides conclusions that can be implemented in practice as well as an algorithm for the bedside clinician and also focuses on the controversies with regard to diagnostic tools and approaches, treatment plans, and prevention strategies.

Patients in the intensive care unit (ICU) are at risk for dying not only from their critical illness but also from secondary processes such as nosocomial infection. Pneumonia is the second most common nosocomial infection in critically ill patients, affecting 27% of all critically ill patients (170). Eighty-six percent of nosocomial pneumonias are associated with mechanical ventilation and are termed ventilator-associated pneumonia (VAP). Between 250,000 and 300,000 cases per year occur in the United States alone, which is an incidence rate of 5 to 10 cases per 1,000 hospital admissions (134, 170). The mortality attributable to VAP has been reported to range between 0 and 50% (10, 41, 43, 96, 161).

A new type of air filter has the potential to work faster, cheaper and better than any other, killing virtually all airborne bacteria and viruses in a fraction of a second.

It’s a germaphobes dream, and a bullish weapon against the spread of infectious diseases, some of which, like measles, can remain suspended in the air for hours on end.

The new device is not only effective at killing viruses, it can actually prevent disease. And if the technology can be miniaturised, the authors say it may one day replace the century-old face mask, allowing us to breathe clean air on the fly.

Blue Origin just announced the timing of its next rocket launch — and it’s surprisingly soon, in just two days, on Thursday, September 24. The launch of Blue Origin’s New Shepard vehicle will be its thirteenth overall for that category of launch craft, and the seventh in a row for this particular rocket. The payload will include an even dozen commercial cargo items, including a Deorbit, Descent and Landing Sensor Demonstration done in partnership with NASA — basically a highly precise automated landing system that will help NASA land on the moon and eventually Mars.

That payload is unique not just because of the technology involved in the landing system, but also because it’ll actually be mounted to the exterior of the New Shephard’s booster stage, rather than in the capsule that rides atop it. This is the first time that Blue Origin has carried a payload this way, and the company expects it could pave the way for similar future missions, enabling sensing at high altitudes, and experiments made possible through use of equipment exposed to the external environment.

NASA to test precision automated landing system designed for the moon and Mars on upcoming Blue Origin mission

Las Vegas hosted two successful test flights using unmanned aircraft to carry human organs and tissue last week. On Sept. 17th, MissionGo, a provider of unmanned aviation solutions and Nevada Donor Network, conducted two unmanned flights — one of which was the longest organ delivery flight in Unmanned Aircraft System (UAS) history. The first flight involved transport of research corneas fromSouthern Hills Hospital and Medical Center to Dignity Health — St. Rose Dominican, San Martín Campus.

Data from Southwest Research Institute-led instruments aboard ESA’s Rosetta spacecraft have helped reveal auroral emissions in the far ultraviolet around a comet for the first time.

At Earth, auroras are formed when charged particles from the Sun follow our planet’s to the north and south poles. There, solar particles strike atoms and molecules in Earth’s atmosphere, creating shimmering curtains of colorful light in high-latitude skies. Similar phenomena have been seen at various planets and moons in our and even around a distant star. SwRI’s instruments, the Alice far-ultraviolet (FUV) spectrograph and the Ion and Electron Sensor (IES), aided in detecting these novel phenomena at 67P/Churyumov-Gerasimenko (67P/C-G).

“Charged particles from the Sun streaming towards the comet in the solar wind interact with the gas surrounding the comet’s icy, dusty nucleus and create the auroras,” said SwRI Vice President Dr. Jim Burch who leads IES. “The IES instrument detected the electrons that caused the aurora.”

Physicist Jim Al-Khalili routinely deals with the strangest subject in all of science — quantum physics, the astonishing and perplexing theory of sub-atomic particles. But now he’s turning his attention to the world of nature. Can quantum mechanics explain the greatest mysteries in biology?

His first encounter is with the robin. This familiar little bird turns out to navigate using one of the most bizarre effects in physics — quantum entanglement, a process which seems to defy common sense. Even Albert Einstein himself could not believe it.

Jim finds that even the most personal of human experiences — our sense of smell — is touched by ethereal quantum vibrations. According to the latest experiments, it seems that our quantum noses are listening to smells. Jim then discovers that the most famous law of quantum physics — the uncertainty principle — is obeyed by plants and trees as they capture sunlight during the vital process of photosynthesis.

Finally, Jim asks if quantum physics might play a role in evolution. Could the strange laws of the sub-atomic world, which allow objects to tunnel through impassable barriers in defiance of common sense, effect the mechanism by which living species evolve?